PDCD1 and neoplasm: The contrast revealed that PD-1 inhibitors could treat B16 tumors in aged hosts as effectively as in young hosts whereas PD-L1 inhibitors failed to exert potent anti-tumor effect in the same condition of aged hosts (76).